+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes



Proton therapy for spinal ependymomas: planning, acute toxicities, and preliminary outcomes



International Journal of Radiation Oncology, Biology, Physics 83(5): 1419-1424



To report acute toxicities and preliminary outcomes for pediatric patients with ependymomas of the spine treated with proton beam therapy at the MD Anderson Cancer Center. Eight pediatric patients received proton beam irradiation between October 2006 and September 2010 for spinal ependymomas. Toxicity data were collected weekly during radiation therapy and all follow-up visits. Toxicities were graded according to the Common Terminology Criteria for Adverse Events version 3.0. All patients had surgical resection of the tumor before irradiation (7 subtotal resection and 1 gross total resection). Six patients had World Health Organization Grade I ependymomas, and two had World Health Organization Grade II ependymomas. Patients had up to 3 surgical interventions before radiation therapy (range, 1-3; median, 1). Three patients received proton therapy after recurrence and five as part of their primary management. The entire vertebral body was treated in all but 2 patients. The mean radiation dose was 51.1 cobalt gray equivalents (range, 45 to 54 cobalt gray equivalents). With a mean follow-up of 26 months from the radiation therapy start date (range, 7-51 months), local control, event-free survival, and overall survival rates were all 100%. The most common toxicities during treatment were Grade 1 or 2 erythema (75%) and Grade 1 fatigue (38%). No patients had a Grade 3 or higher adverse event. Proton therapy dramatically reduced dose to all normal tissues anterior to the vertebral bodies in comparison to photon therapy. Preliminary outcomes show the expected control rates with favorable acute toxicity profiles. Proton beam therapy offers a powerful treatment option in the pediatric population, where adverse events related to radiation exposure are of concern. Extended follow-up will be required to assess for late recurrences and long-term adverse effects.

(PDF emailed within 0-6 h: $19.90)

Accession: 055260527

Download citation: RISBibTeXText

PMID: 22245209

DOI: 10.1016/j.ijrobp.2011.10.034


Related references

Spot scanning proton therapy for malignancies of the base of skull: treatment planning, acute toxicities, and preliminary clinical outcomes. International Journal of Radiation Oncology, Biology, Physics 90(3): 540-546, 2015

Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system. International Journal of Radiation Oncology, Biology, Physics 90(5): 1143-1152, 2015

Surgical technique and outcomes in the treatment of spinal cord ependymomas, part 1: intramedullary ependymomas. Neurosurgery 68(1 Suppl Operative): 57-63; Discussion 63, 2011

Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation. Neuro-Oncology 16(2): 303-309, 2014

Adjuvant Proton Beam Therapy in the Management of Thymoma: A Dosimetric Comparison and Acute Toxicities. Clinical Lung Cancer 17(5): 362-366, 2016

A treatment planning study of proton arc therapy for para-aortic lymph node tumors: dosimetric evaluation of conventional proton therapy, proton arc therapy, and intensity modulated radiotherapy. Radiation Oncology 11(1): 140, 2016

Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial. International Journal of Radiation Oncology, Biology, Physics 90(3): 493-500, 2015

Proton beam therapy reduces the incidence of acute haematological and gastrointestinal toxicities associated with craniospinal irradiation in pediatric brain tumors. Acta Oncologica 53(9): 1158-1164, 2015

(P086) Proton vs Photon/Electron-Based Therapy in the Treatment of Pediatric Salivary Gland Tumors: A Comparison of Dosimetric Data and Acute Toxicities. Oncology 29(4 Suppl 1): -, 2015

Outcomes in treatment for intradural spinal cord ependymomas. International Journal of Radiation Oncology, Biology, Physics 69(4): 1199-1204, 2007

Outcomes in treatment for primary spinal anaplastic ependymomas: a retrospective series of 20 patients. Journal of Neurosurgery. Spine 19(1): 3-11, 2013

Spinal cord ependymomas and myxopapillary ependymomas in the first 2 decades of life: a clinicopathological and immunohistochemical characterization of 19 cases. Journal of Neurosurgery. Pediatrics 9(6): 646-653, 2012

Surgical technique and outcomes in the treatment of spinal cord ependymomas: part II: myxopapillary ependymoma. Neurosurgery 68(1 Suppl Operative): 90-4; Discussion 94, 2011

An integrative analysis of treatment, outcomes and prognostic factors for primary spinal anaplastic ependymomas. Journal of Clinical Neuroscience 22(6): 976-980, 2016

Surgical strategies and outcomes of spinal ependymomas of different lengths: analysis of 210 patients: clinical article. Journal of Neurosurgery. Spine 21(2): 249-259, 2014